Coronavirus: Vaccines can carry some mild side-effects, say experts

Sun Online Desk

30th July, 2020 11:13:03 printer

Coronavirus: Vaccines can carry some mild side-effects, say experts

With speedy developments being done by medical research groups to develop a vaccine to fight COVID-19, the world is ardently waiting to see a vaccine being deployed for public use.

While there is still a lot more data needed to confirm the working of these vaccines, one thing experts want to warn the public about are the potential side-effects, which can happen post-inoculation.

Can we pin our hopes on a vaccine yet?

Experts based out of the University of North Carolina, USA, who have been closely monitoring the data from preliminary trials and researches say that while many of the vaccines currently in development have proven to be effective in neutralizing the virus and elicit a safe immune response, the biggest shortcoming has been the occurrence of side-effects.

Moderna, Oxford in late stage clinical trials

With speedy developments being done by medical research groups to develop a vaccine to fight COVID-19, the world is ardently waiting to see a vaccine being deployed for public use. As many as 5 research groups have reached phase III of their clinical trials and seeking to put out a vaccine before 2020. Preliminary data from early-stage trials have presented a lot of takeaways, both good and bad. While there is still a lot more data needed to confirm the working of these vaccines, one thing experts want to warn the public about are the potential side-effects, which can happen post-inoculation.

Can we pin our hopes on a vaccine yet?

Experts based out of the University of North Carolina, USA, who have been closely monitoring the data from preliminary trials and researches say that while many of the vaccines currently in development have proven to be effective in neutralizing the virus and elicit a safe immune response, the biggest shortcoming has been the occurrence of side-effects.

Moderna, Oxford in late stage clinical trials

Both Moderna Inc. and Oxford-AstraZeneca developed vaccines, which are currently leading the race showcased good results in early trials. The participants in the trial recorded mild to moderate symptoms post injection of the vaccine.


Top